Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 8, No 6 (2012) ASSESSMENT OF DIABETES RISK IN MEN WITH DIFFERENT LEVELS OF CARDIOVASCULAR RISK Abstract  similar documents
M. N. Kovrigina, M. N. Mamedov
"... Aim. To assess the risk of diabetes mellitus type 2 (DM2) in patients with various cardiovascular ..."
 
Vol 5, No 3 (2009) CARDIOVASCULAR DISEASES TREATMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN CURRENT CLINICAL PRACTICE Abstract  PDF (Eng)  similar documents
I. E. Sapozhnikova, E. I. Tarlovskaya, E. N. Anufrieva
"... Aim. To evaluate cardiovascular diseases (CVD) treatment in patients with type 2 diabetes mellitus ..."
 
Vol 4, No 2 (2008) COMPARISON OF CARVEDILOL AND BISOPROLOL EFFICACY IN PATIENTS WITH CHRONIC HEART FAILURE AND DIABETES TYPES 2 AFTER MYOCARDIAL INFARCTION Abstract  similar documents
M. E. Statsenko, S. V. Belenkova, O. E. Sporova, D. A. Ivanova, E. D. Evtereva
"... ) and diabetes mellitus (DM) type 2 after myocardial infarction (MI). Material and methods. 60 patients (45-70 y ..."
 
Vol 10, No 3 (2014) ENDOTHELIAL-TROPIC AND NEPHROPROTECTIVE EFFECTS OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS Abstract  similar documents
M. E. Statsenko, M. V. Derevyanchenko, M. N. Titarenko, O. R. Pastuchova
"... hypertension (HT) and diabetes mellitus (DM) type 2. Material and methods. 30 hypertensive patients with DM ..."
 
Vol 16, No 4 (2020) The Peculiarity of Process and Treatment of Arterial Hypertension in Patients with Type 2 Diabetes Mellitus Abstract  similar documents
T. Yu. Demidova, O. A. Kislyak
"... of type 2 diabetes mellitus and AH dramatically increases the risk of developing terminal stages ..."
 
Vol 11, No 2 (2015) DIAGNOSTIC VALUE OF GALECTIN-3 LEVEL IN PATIENTS WITH CHRONIC HEART FAILURE AND TYPE 2 DIABETES Abstract  similar documents
A. A. Snetkova, N. Yu. Timofeeva, V. S. Zadionchenko
"... in many studies, but the dynamics of its levels in patients with concomitant diabetes mellitus (DM) type 2 ..."
 
Vol 14, No 6 (2018) Effectiveness of Chrono-Pharmacotherapy Depending on the Salt Sensitivity of Patients with Arterial Hypertension and Diabetes Mellitus Type 2 Abstract  PDF (Eng)  similar documents
V. V. Skibitskiy, A. A. Kiselev, A. V. Fendrikova
"... on the salt sensitivity of hypertensive patients with diabetes mellitus type 2. Material and methods. 130 ..."
 
Vol 5, No 5 (2009) ANOTHER LOOK AT TYPE 2 DIABETES PATIENT: “DIALOGUE” STUDY RESULTS Abstract  similar documents
I. E. Sapozhnikova, E. I. Tarlovskaya, E. N. Anufrieva, A. A. Sobolev, E. V. Rodygina
"... Aim. To evaluate factors affecting hypoglycemic therapy in patients with type 2 diabetes mellitus ..."
 
Vol 12, No 1 (2016) State of a large vessels and microcirculation - a new target for antihypertensive therapy in patients with hypertension and type 2 diabetes Abstract  similar documents
M. E. Statsenko, M. V. Derevyanchenko
"... ) in patients with arterial hypertension (HT) and diabetes mellitus (DM) type 2. Material and methods. 30 ..."
 
Vol 15, No 3 (2019) Vascular Remodeling Markers in Patients with Essential Arterial Hypertension Depending on Presence of Type 2 Diabetes Mellitus Abstract  similar documents
Yu. A. Danilogorskaya, E. A. Zheleznykh, E. A. Privalova, Yu. N. Belenkov, A. A. Shchendrigina, M. V. Kozhevnikova, G. A. Shakaryants, V. Y. Zektser, A. S. Lishuta, I. S. Ilgisonis
"... of type 2 diabetes mellitus. Material and methods. The study included patients with essential hypertension ..."
 
Vol 12, No 2 (2016) THE INTERIM EXPERTS’ COUNCIL RESOLUTION ON THE EMPA-REG OUTCOME TRIAL ISSUES Abstract  similar documents
M. V. Shestakova, S. A. Boytsov, O. M. Drapkina, T. Yu. Demidova, H. Drexel, M. B. Antsiferov, N. A. Petunina, N. A. Chernikova, V. Yu. Kalashnikov, T. P. Bardymova, V. K. Protasov, A. Yu. Babenko, L. A. Ruyatkina, V. V. Klimontov, V. V. Salukhov, V. V. Fadeev, Yu. A. Karpov
"... empagliflozin’s cardiovascular effects investigation and its clinical application in patients with type 2 ..."
 
Vol 15, No 6 (2019) Markers of Endothelial Dysfunction: E-selectin, Endothelin-1 and von Willebrand Factor in Patients with Coronary Heart Disease, Including in Combination with Type 2 Diabetes Mellitus Abstract  similar documents
A. V. Zhito, A. O. Iusupova, E. V. Privalova, N. V. Khabarova, Yu. N. Belenkov
"... The prevalence of coronary heart disease (CHD) and type 2 diabetes mellitus (type 2 diabetes ..."
 
Vol 14, No 5 (2018) Pharmacogenetic and Clinical Predictors of Clopidogrel Insufficiency in a Patient with Atherosclerosis Obliterans of the Lower Extremities: Clinical Case Abstract  similar documents
M. A. Andreyanova, K. B. Mirzaev, D. A. Sychev, K. A. Ryzhikova, A. V. Pokrovsky, A. F. Kharazov
"... with type 2 diabetes mellitus and liver fibrosis demonstrates a combination of polyvalent risk factors ..."
 
Vol 14, No 5 (2018) Impact of Pre-Diabetes on the Rate of Major Adverse Cardiovascular Events in Patients Undergoing Coronary Artery Bypass Grafting Abstract  similar documents
A. N. Sumin, N. A. Bezdenezhnykh, A. V. Bezdenezhnykh, S. V. Ivanov, O. L. Barbarash
"... Aim. To assess  the  relationship between pre-diabetes/type 2 diabetes mellitus (type 2 DM ..."
 
Vol 5, No 3 (2009) COMPARATIVE CONTROLLED STUDY OF ANTIHYPERTENSIVE EFFICACY AND SAFETY OF CARVEDILOL IN PATIENTS WITH HYPERTENSION AND OBESITY OR DIABETES 2 TYPE (BASED ON RESULTS OF MULTICENTER TRIAL ACCORD) Abstract  similar documents
Yu. V. Yu.V. Lukina, S. Yu. Martsevich, A. D. Deev, S. A. Shalnova
"... ) and diabetes mellitus 2 type (DM2) and/or obesity. Material and methods. 592 patients: 176 men (29,7%) and 416 ..."
 
Vol 9, No 4 (2013) STATINS AND THE RISK OF DIABETES MELLITUS Abstract  similar documents
O. M. Drapkina
"... the risk of diabetes mellitus (DM) in long-term therapy and use of high doses. Diabetogenic action ..."
 
Vol 14, No 2 (2018) HYPERTENSION AND DIABETES MELLITUS TYPE 2 Abstract  similar documents
M. E. Statsenko, M. V. Derevyanchenko
"... hypertension (HT) combined with type 2 diabetes mellitus (DM). Material and methods. 30 patients with stage ..."
 
Vol 5, No 6 (2009) INFLUENCE OF ENALAPRIL, DIGOXIN, ATENOLOL AND DILTIAZEM ON LIPID PEROXIDATION IN EXPERIMENTAL MODEL OF COMPLEX METABOLIC DISORDERS Abstract  similar documents
A. A. Usanova, A. A. Aleksandrovsky, A. V. Zorkina, O. M. Kiselеv
 
Vol 11, No 4 (2015) DISORDERS OF THE AUTONOMIC NERVOUS SYSTEM IN THE CARDIOLOGY PRACTICE: FOCUS ON THE ANALYSIS OF HEART RATE VARIABILITY Abstract  similar documents
E. B. Akhmedova, B. U. Mardanov, M. N. Mamedov
"... rhythm disorders, as well as diabetes mellitus (DM) is considered. A significant association between ..."
 
Vol 3, No 2 (2007) OXIDATIVE STRESS AND POSSIBILITY TO CORRECT IT WITH ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN PATIENTS WITH MYOCARDIAL INFARCTION ASSOCIATED WITH DIABETES MELLITUS TYPE 2 Abstract  similar documents
K. S. Lexina, N. Y. Timofeeva, V. S. Zadionchenko, G. G. Shehian, K. A. Aldushina
"... in patients suffering diabetes mellitus type 2, especially to the role of oxidative stress. It is determined ..."
 
Vol 8, No 5 (2012) EFFICACY OF COMBINED ANTIHYPERTENSIVE THERAPY IN ACHIEVEMENT OF TARGET BLOOD PRESSURE IN DIABETIC PATIENTS Abstract  similar documents
O. A. Koshel'skaya, O. A. Zhuravleva, R. S. Karpov
"... patients with diabetes mellitus (DM) in accordance with target blood pressure (BP) <130/80 mm Hg ..."
 
Vol 11, No 5 (2015) Features of the in-hospital course of myocardial infarction in patients with glucose metabolism disorders Abstract  similar documents
B. U. Mardanov, M. N. Mamedov, M. N. Korneeva, R. G. Oganov
"... (STEMI) and the features of inpatient treatment in patients with and without diabetes mellitus (DM ..."
 
Vol 7, No 5 (2011) AMLODIPINE IN CORRECTION OF HIGH RISK ARTERIAL HYPERTENSION: FOCUS ON MECHANISMS OF INFLAMMATION Abstract  similar documents
A. A. Tarasov, S. I. Davydov, T. A. Bezborodova, M. A. Gordeeva, A. R. Babaeva
"... ) or diabetes mellitus (DM) type 2. Material and methods. Patients with HT (2-3 degree) associated with IHD ..."
 
Vol 7, No 5 (2011) CLINICAL EFFICACY OF GLYCOSAMINOGLYCANS IN PATIENTS WITH DIABETES MELLITUS AND ISCHEMIC HEART DISEASE Abstract  similar documents
L. V. Kozlova, R. A. Khokhlov, N. M. Akhmedzhanov
"... Aim. To study sulodexide clinical efficacy in patients with type 2 diabetes mellitus (DM ..."
 
Vol 9, No 4 (2013) EFFECTS OF ATORVASTATIN ON ENDOTHELIAL DYSFUNCTION IN TYPE 2 DIABETIC PATIENTS WITH DIFFERENT DURATION F THE DISEASE Abstract  PDF (Eng)  similar documents
G. A. Batrak, S. E. Miasoedova, O. I. Kelesh
"... Aim. To evaluate dynamics of endothelial vasoregulatory function in type 2 diabetic patients after ..."
 
Vol 8, No 1 (2012) BETA-BLOCKERS IN THE TREATMENT OF ARTERIAL HYPERTENSION: EVIDENCE BASED DATA AND REAL PRACTICE Abstract  similar documents
M. V. Leonova
"... in hypertensive patients with diabetes mellitus and chronic heart failure are discussed. Special attention is paid ..."
 
Vol 8, No 1 (2012) PRIMARY PREVENTION OF DIABETES MELLITUS: CORRECTION OF EARLY DISORDERS OF GLUCOSE METABOLISM IN CARDIOLOGY PRACTICE Abstract  similar documents
M. N. Mamedov, E. A. Poddubskaya, M. N. Kovrigina, Z. O. Ugurchieva, R. T. Digigova
"... to prevention of type 2 diabetes mellitus (DM). Data of international clinical trials shows that early GMD ..."
 
Vol 4, No 2 (2008) ACUTE CORONARY SYNDROME IN PATIENTS WITH DIABETES MELLITUS: ON THE WAY TO MUNICH-2008 Abstract  similar documents
I. I. Dedov, A. A. Alexanrov
"... tolerance disturbances including 44% of patient with these reaching the level of diabetes mellitus (DM ..."
 
Vol 12, No 4 (2016) Fighting with obesity: the "gold standard" and new horizons Abstract  similar documents
O. M. Drapkina, Yu. V. Dubolazova, S. A. Boytsov
"... , such as cardiovascular disease and type 2 diabetes. Therapy aimed at addressing the risk factors of adverse outcomes ..."
 
Vol 13, No 1 (2017) QUALITY OF LIFE, CLINICAL AND BIOCHEMICAL PARAMETERS IN HYPERTENSIVE PATIENTS WITH COMORBID CONDITIONS Abstract  similar documents
E. B. Akhmedova, B. U. Mardanov, K. K. Badeynikova, M. N. Mamedov
"... with HT (I group, n=20; 52.7±9.9 years old); patients with HT and diabetes mellitus (DM) type 2 (II group ..."
 
Vol 10, No 3 (2014) THE SAFETY OF STATINS: WHAT A PHYSICIAN NEEDS TO KNOW Abstract  similar documents
D. A. Napalkov
"... , myopathy and rhabdomyolysis, the impact on the diabetes and cognitive dysfunction onset, renal function ..."
 
Vol 6, No 3 (2010) EFFECT OF COMPLEX HOMEOPATHIC DRUG CONTAINING COENZYME Q ON PARAMETERS OF OXIDATIVE STRESS AND HEMODYNAMICS IN EXPERIMANTAL DIABETES MELLITUS Abstract  similar documents
S. G. Dzugkoev, V. A. Metelskaya, I. V. Mozhaeva, F. S. Dzugkoeva
"... in experimental diabetes mellitus. Materials and methods. Diabetes mellitus was induced by the administration ..."
 
Vol 15, No 1 (2019) How Does the Presence of Diabetes Affect the Course of Acute Coronary Syndrome in Elderly Patients in Actual Clinical Practice? Abstract  similar documents
M. R. Atabegashvili, E. V. Konstantinova, M. D. Muksinova, A. E. Udovichenko, A. P. Nesterov, M. O. Zheltoukhova, L. S. kyzy Muradova, M. Y. Gilarov
"... The number of elderly patients with diabetes mellitus (DM) is constantly growing in general ..."
 
Vol 15, No 3 (2019) Features of Atrial Fibrillation in Patients with Arterial Hypertension and Extracardial Disorders Abstract  similar documents
L. D. Khidirova, D. A. Yakhontov, S. A. Zenin, M. N. Mamedov
"... comorbid extracardiac diseases: diabetes mellitus (DM; n=40), diffuse toxic goiter (DTG; n=42 ..."
 
Vol 9, No 1 (2013) MYOCARDIAL FIBROSIS IN PATIENTS WITH DIABETES MELLITUS Abstract  similar documents
O. M. Drapkina, B. B. Gegenava
"... The mechanism of myocardial damage in diabetes mellitus is considered. The pathogenesis ..."
 
Vol 14, No 5 (2018) Basic Anthropometric Indices and Diabetes Mellitus Type 2 in Russian Population Abstract  similar documents
O. M. Drapkina, R. N. Shepel, S. A. Shalnova, A. D. Deev, Yu. A. Balanova, S. E. Evstifeeva, Yu. V. Zhernakova, A. E. Imaeva, A. V. Kapustina, G. A. Muromtseva, O. P. Rotar, E. V. Shlyakhto, S. A. Boytsov
"... Obesity is one of the main risk factors for type 2 diabetes developing. The question ..."
 
Vol 8, No 3 (2012) EFFECT OF THE COMBINED ANTIHYPERTENSIVE THERAPY WITH TARGET BLOOD PRESSURE ACHIEVEMENT ON INTRARENAL BLOOD FLOW IN PATIENTS WITH TYPE 2 DIABETES Abstract  similar documents
O. A. Koshel'skaya, O. A. Zhuravleva
"... 2 diabetes mellitus (DM) who achieved the target BP levels (<130/80 mmHg) due to long-term combined ..."
 
Vol 15, No 6 (2019) Myocardial Infarction with Non-Obstructive Coronary Arteries: Contemporary Diagnostic and Management Approaches Abstract  similar documents
T. H. Hoang, P. V. Lazarev, V. V. Maiskov, A. I. Meray, Zh. D. Kobalava
 
Vol 9, No 1 (2013) EFFECT OF DIFFERENT GLUCOSE BLOOD LEVELS ON THE DEVELOPMENT OF CARDIOVASCULAR DISEASES AND COMPLICATIONS Abstract  similar documents
E. V. Akhmedova, Z. A. Toguzova, M. N. Mamedov
"... Diabetes mellitus (DM) is one of the health and social problems of modern health care. The main ..."
 
Vol 4, No 1 (2008) WHAT CAN WE EXPECT USING ACE INHIBITOR RAMIPRIL IN PERSONS WITH HIGH CARDIOVASCULAR RISK AND EARLY DISORDERS OF CARBOHYDRATE METABOLISM? LESSONS OF DREAM TRIAL Abstract  similar documents
M. N. Mamedov, M. B. Stroeva
"... Primary prevention of diabetes in persons with high cardiovascular risk is an actual problem ..."
 
Vol 12, No 6 (2016) HEART FAILURE AND DIABETES MELLITUS: SELECTED ISSUES OF ETIOLOGY AND PATHOGENESIS, PROGNOSIS AND TREATMENT Abstract  similar documents
B. U. Mardanov, M. N. Korneeva, E. B. Akhmedova
"... of chronic heart failure (CHF) and diabetes mellitus (DM). The modern views on the epidemiology, pathogenesis ..."
 
Vol 6, No 6 (2010) REDUCTION OF CARDIOVASCULAR COMPLICATIONS OF MODERN HYPOGLYCEMIC THERAPY OF DIABETES MELLITUS TYPE 2: "FLORENTINE HERESY" Abstract  similar documents
A. A. Aleksandrov
"... , the effect of combined hypoglycemic therapy on long-term cardiovascular prognosis in patients with type 2 ..."
 
Vol 11, No 2 (2015) THE INFLUENCE OF INSULIN RESISTANCE ON THE FORMATION AND PROGRESSION OF METABOLIC SYNDROME COMPONENTS (THE RESULTS OF A FIVE-YEAR STUDY) Abstract  similar documents
G. E. Roytberg, J. V. Dorosh, O. O. Sharkhun
"... of cardiovascular disease and type 2 diabetes. In the presence of insulin resistance the effects of risk factors ..."
 
Vol 5, No 6 (2009) INTERNATIONAL DIABETES FEDERATION CONSENSUS ON DEFINITION OF THE METABOLIC SYNDROME: FACTS AND COMMENTS Abstract  similar documents
M. N. Mamedov
"... International Diabetes Federation consensus, devoted to definition of the metabolic syndrome ..."
 
Vol 4, No 3 (2008) HEART FAILURE, DIABETES, BETA-BLOCKERS AND RISK OF HYPOGLYCEMIA Abstract  similar documents
A. A. Aleksandrov, O. А. Shatskaya, S. S. Kuharenko, E. N. Drozdova, I. Z. Bondarenko, N. D. Tabidze, M. V. Shestakova
"... Aim. To evaluate an influence of carvedilol on risk of hypoglycemia in patients with diabetes type ..."
 
Vol 7, No 6 (2011) PHARMACOTHERAPY ANALYSIS OF ACUTE ST-ELEVATION MYOCARDIAL INFARCTION IN HOSPITALS OF VARIOUS TYPES Abstract  similar documents
R. M. Magdeev, O. V. Reshetko, E. Y. Rudnichenko, N. V. Furman, P. V. Dolotovskaya, T. Y. Grozdova, L. N. Volkova
"... departments of Saratov hospitals of various types. Material and methods. The retrospective ..."
 
Vol 11, No 1 (2015) METABOLIC EFFECTS OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH TYPE 2 DIABETES Abstract  similar documents
M. E. Statsenko, M. V. Derevyanchenko
"... hypertension (HT) and diabetes mellitus (DM) type 2. Material and methods. 30 patients with HT stage II-III ..."
 
Vol 3, No 5 (2007) LISINOPRIL USAGE IN CARDIOLOGIC PRACTICE: DATA OF EVIDENCE BASED MEDICINE Abstract  similar documents
N. P. Kutishenko, S. J. Martsevich
"... complicated with left ventricle dysfunction and diabetes (GISSI-3, ATLAS, ALLHAT, EUCLID) are presented ..."
 
Vol 16, No 1 (2020) Patients with Combination of Cardiovascular Diseases and Type 2 Diabetes in RECVASA and REGION Registries: Multimorbidity, Outcomes and Potential Effect of Dapagliflozin in the Russian Clinical Practice Abstract  similar documents
M. M. Loukianov, A. V. Kontsevaya, A. O. Myrzamatova, M. B. Khudyakov, E. Y. Okshina, E. V. Kudryashov
"... of dapagliflozin in patients with a combination of cardiovascular disease (CVD) and type 2 diabetes in Russian ..."
 
Vol 6, No 4 (2010) CLOPIDOGREL PHARMACOGENETICS Abstract  similar documents
A. N. Meshkov
"... agents all over the world is clopidogrel, R2Y12-receptor blocker. It is shown that clopidogrel has ..."
 
Vol 11, No 4 (2015) INFLUENCE OF THE CYP3A4 ISOENZYME METABOLIC ACTIVITY AND CYP2C19 GENE POLYMORPHISMS ON CLOPIDOGREL ANTIPLATELET EFFECT IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION Abstract  PDF (Eng)  similar documents
K. B. Mirzaev, R. E. Kazakov, V. V. Smirnov, D. A. Andreev, D. A. Sychev
"... Aim. Carriership of CYP2C19*2 allelic variant and reduced CYP3A4 activity can affect the formation ..."
 
Vol 9, No 4 (2013) THE SIGNIFICANCE OF PHARMACOGENETIC CYP2C19 TESTING FOR PERSONALIZATION OF THE ANTIPLATELET THERAPY IN CARDIOLOGY PRACTICE Abstract  similar documents
K. B. Mirzaev, D. A. Sychev, D. A. Andreev, A. B. Prokofiev
"... The clinical significance  of CYP2C19 genetic polymorphism, associated with the violation ..."
 
Vol 14, No 1 (2018) NFLUENCE OF CYP4F2*3 ON RESPONSE TO CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME Abstract  similar documents
K. B. Mirzaev, O. D. Konova, E. A. Grishina, K. A. Ryzhikova, Zh. A. Sozaeva, D. A. Andreev, M. Y. Gilyarov, D. A. Sychev
"... Background. Carriership of CYP4F2*3 (rs2108622, Val433Met) allelic variant can affect antiplatelet ..."
 
Vol 11, No 2 (2015) COMPARATIVE EVALUATION OF HEMODYNAMIC CHARACTERISTICS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND ARTERIAL HYPERTENSION Abstract  similar documents
Y. E. Teregulov, D. K. Husainova, D. I. Abdulganeeva, S. D. Mayanskaya
"... patients had same types of hemodynamics in 3.2%, 61.9%, and 34.9%, respectively. In healthy people ..."
 
Vol 11, No 3 (2015) PREVALENCE OF TYPE D PERSONALITY AND ITS ASSOCIATION WITH CARDIOVASCULAR DISEASES AND THEIR RISK FACTORS ACCORDING TO THE ESSE STUDY CONDUCTED IN KEMEROVO REGION Abstract  similar documents
A. N. Sumin, O. I. Raykh, E. V. Indukaeva, G. V. Artamonova
"... ) and patients without type D personality (n=1379). Arterial hypertension, smoking, diabetes ..."
 
Vol 6, No 4 (2010) ACC/AHA CLOPIDOGREL CLINICAL ALERT. WHAT MUST BE MODERN ANTIPLATELET THERAPY? Abstract  similar documents
S. J. Martsevich
 
Vol 6, No 5 (2010) THE POLYMORPHISM OF Α2B-ADRENERGIC RECEPTOR GENE — A NEW GENETIC MARKER OF THE HEREDITARY SICK SINUS SYNDROME Abstract  similar documents
S. Iu. Nikulina, V. A. Shulman, A. A. Chernova, D. A. Nikulin, M. I. Voevoda, V. N. Maksimov
"... their healthy relatives, 89 healthy volunteers. Results. 3 types of ADRA2B genotypes (II — homozygous wild, ID ..."
 
Vol 14, No 6 (2018) Antithrombotic Therapy in Patients with Atrial Fibrillation after Myocardial Infarction: Clinical Guidelines and Actual Practice Abstract  PDF (Eng)  similar documents
K. G. Pereverzeva, S. S. Yakushin, A. E. Pripadcheva, N. P. Agaltsova
"... performed for 104 patients. In 64 (60.2%) of cases, AF was presented by paroxysmal form, while in 2 (1 ..."
 
Vol 14, No 2 (2018) PHARMACOECONOMIC ANALYSIS OF CHRONIC HEART FAILURE DRUG THERAPY IN PATIENTS WITH COMORBID CONDITIONS Abstract  similar documents
S. K. Zyryanov, A. E. Cheberda, D. Yu. Belousov
"... complex compared to routine therapy in patients with diabetes type 2 and ACE inhibitor intolerance within ..."
 
Vol 8, No 3 (2012) THE EFFICACY OF COMBINED BIOMARKER TESTS IN EARLY DIAGNOSTICS OF ACUTE MYOCARDIAL INFARCTION AFTER CLINICAL SYMPTOMS ONSET: ROLE OF HEART-TYPE FATTY ACID-BINDING PROTEIN Abstract  similar documents
O. V. Baturina, S. R. Gilyarevsky, I. M. Kuzmina, M. A. Godkov, E. V. Klychnikova
"... Aim. To evaluate the diagnostic value of heart-type fatty acid-binding protein (H-FABP ..."
 
Vol 13, No 4 (2017) FEATURES OF CEREBRAL HEMODYNAMICS AND MANIFESTATIONS OF HEPATIC ENCEPHALOPATHY IN CIRRHOSIS OF VIRAL ETIOLOGY AT DIFFERENT COMPENSATION STAGES WITH PRESERVED LEFT VENTRICULAR EJECTION FRACTION Abstract  similar documents
V. E. Kulikov, T. A. Emelina, O. G. Kazakova, K. V. Nikolaevа, M. E. Hapman, M. A. Tonеeva
"... of interleukin-2, interleukin-6 and tumor necrosis factor alpha and preserved left ventricular ejection fraction ..."
 
Vol 13, No 6 (2017) CYP2C19 PHARMACOGENETIC TESTING FOR PERSONALIZATION OF ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME IN ROUTINE CLINICAL PRACTICE Abstract  similar documents
A. I. Akhmetova, E. B. Kleimenova, D. A. Sychev, O. V. Parshina, L. P. Yashina
"... Aim. To study the use of CYP2C19 pharmacogenetic testing (PhGT) for personalization ..."
 
Vol 14, No 1 (2018) NEW APPROACHES TO INDIVIDUALIZED CHOICE OF ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
Ju. P. Skirdenko, N. A. Nikolayev
"... , polymorphism of genes CYP2C9 and VKORC1 and the structure of food preferences. Results. Persons ..."
 
Vol 3, No 2 (2007) VARFARIN DOSE REGIME APPROACHS BASED ON PHARMACOGENETICS TEST RESULTS: REAL POSSIBILITY TO OPTIMIZE THE PHARMACOTHERAPY Abstract  similar documents
D. A. Sychev, I. M. Antonov, S. V. Zagrebin, N. A. Gasanov, V. G. Kukes
"... of polymorphisms of genes of their biotransformation (CYP2C9) and molecule-targets (VKORC1). This created basis ..."
 
Vol 8, No 5 (2012) TITERS OF ANTIBODIES TO Β1-ADRENOCEPTOR AND M2 CHOLINERGIC RECEPTORS IN PATIENTS WITH VENTRICULAR ARRHYTHMIAS WITHOUT AN ORGANIC CARDIOVASCULAR DISEASE AND THEIR POSSIBLE CLINICAL SIGNIFICANCE Abstract  similar documents
M. M. Rogova, N. A. Mironova, E. S. Rodionova, T. A. Malkina, K. A. Zykov, Zh. D. Bespalova, R. Sh. Bibilashvili, E. E. Efremov, S. P. Golitsyn
"... Aim. To identify the most promising epitopes that simulate various sites β1-adrenergic and M2 ..."
 
Vol 12, No 5 (2016) Treatment Adherence as a New Choice Factor for Optimization of Oral Anticoagulation Therapy in Patients with Atrial Fibrillation and Hemostatic Gene Polymorphisms Abstract  PDF (Eng)  similar documents
Yu. P. Skirdenko, A. V. Shustov, V. V. Zherebilov, N. A. Nikolayev
"... Aim. To evaluate treatment adherence and prevalence of CYP2C9 and VKORC1 gene mutations ..."
 
Vol 12, No 6 (2016) POSSIBLE CHANGES IN THE CENTRAL HEMODYNAMICS IN PORTAL HYPERTENSION DUE TO LIVER CIRRHOSIS OF VIRAL ETIOLOGY WITH DIFFERENT LEVELS OF CYTOKINES Abstract  similar documents
V. E Kulikov, T. A. Emelina, O. G. Kazakova, K. V. Nikolaevа, M. E. Hapman, M. A. Tonеeva
"... (interleukin-2, interleukin-6, tumor necrosis factor alpha). Results. Significant changes in the central ..."
 
Vol 9, No 5 (2013) APPLICATIONS OF PHARMACOGENETIC TESTING FOR PERSONALIZATION OF THERAPY WITH ORAL ANTICOAGULANTS IN RUSSIA Abstract  similar documents
D. A. Sychev, R. E. Kazakov, V. A. Otdelenov, A. B. Prokofiev
 
Vol 14, No 6 (2018) P2Y12 Receptor Inhibitors in the Treatment of Patients with Acute Coronary Syndrome and Percutaneous Coronary Intervention: Possibilities of Prasugrel Abstract  PDF (Eng)  similar documents
N. M. Vorobyeva
"... The possibilities of P2Y12 receptor inhibitors application in the treatment of patients with acute ..."
 
Vol 8, No 6 (2012) GENETIC PREDICTORS OF IDIOPATHIC SICK SINUS SYNDROME Abstract  similar documents
A. A. Chernova, S. Yu. Nikulina, S. S. Tret'yakova
 
1 - 70 of 70 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)